WUOF

Fifth Conference of the World Urologic Oncology Federation
Urologic Oncology in the Aging Population
Chair: Laurence Klotz, Canada

Saturday, October 15
0800-0915	SESSION ONE | Prostate Cancer Prevention
	Diet, Statins, Cholesterol: Hanjong Ahn, South Korea
	Pre-clinical models of Prostate Cancer Prevention. Hirotsugu Uemura, Japan
	Curcumin and Other Micronutrients: Shigeo Horie, Japan
	Nutraceuticals and Prostate Cancer: Neil Fleshner, Canada
	Exercise: Arturo Mendoza Valdes, Mexico
0930	SESSION TWO | Town Hall Forum Screening in Men Over Age 65: Case and Discussion
	Lessons from ERSPC: Monique Roobol, The Netherlands
	Adapting Treatment Strategies for CRPC in the Elderly: Fred Saad, Canada
	An Epidemiologic Perspective: Peter Albertsen, USA
	Pros and Cons: Franz Recker, Switzerland
1030	Break
1045	SESSION THREE | Update on Biomarkers
	PCA3: Inge Van Oort, The Netherlands
	Seminal Fluid Markers: Frank Gardiner, Australia
	Serum Biomarkers: John Davis, USA
	Angiogenesis and Lymphangiogenesis in Prostate Cancer: Derya Tilki, Germany
	MRI and Prostate Cancer Staging: Mark Emberton, UK
	Role of Staging Template Biopsies: David Crawford, USA
	Discussion
1230	LUNCH
1300	SESSION FOUR | Mechanisms of Castrate Resistance
	AR-mTOR: James Mohler, USA
	Autophagy and Prostate Cancer: Christopher Evans
	Clusterin and ERK: TBA
	Prostate Cancer Stem Cells: Johannes Vieweg, USA
	Immune Escape and Prostate Cancer: Rob Siemens, Canada
	Discussion
1430	SESSION FIVE | Treatment
	Timing of Hormonal Therapy in the Elderly: Urs Studer, Switzerland
	Focal MR-Guided Thermotherapy: An Update: John Trachtenberg, Canada
	How Should ADT Be Used in the Elderly? Impact of Cardiovascular Comorbidity: Thomas Keane, USA
1510	BREAK
1530	SESSION SIX | Kidney Small Renal Masses: Indications for Intervention in Elderly Patients: Tony Finelli, Canada
	Partial Nephrectomy in the Elderly: Thomas Schwaab, USA
	Role of Biopsy in Management of Renal Masses: Michael Jewett, Canada
	Incorporation TKIs into Surgical Management: Anil Kapoor, Canada
	Nomograms in Decision Making in Renal Cancer: Robert Uzzo, USA
	Case Discussion: Management of Small Masses
1700	CONCLUDE
Sunday, October 16
0800	SESSION SEVEN | Bladder Cancer Biology
	Update on New Diagnostic Methods: Fred Witjes, The Netherlands
	Tissue Markers: Peter Black, Canada
	Deterioration of Physiologic Competence and Reserve with Aging: Considerations for Treatment Decisions in Bladder Cancer: Michael Droller, USA
	SNPs and Bladder Cancer Progression: Wun-Jae Kim, South Korea
	Lymphangiogenesis and GU Cancer: TBA
	Use of Nomograms in Bladder Cancer: Shahrokh Shariat, USA
	Discussion
0945	SESSION EIGHT | Surgical Management of Invasive Bladder Cancer
	Role of Extended Node Dissection: Wassim Kassouf, Canada
	Orthotopic Bladder in Elderly Patients: Limits and Results: Richard Hautmann, Germany
	Robotic Cystectomy: Results and Technique: Alexander Mottrie, Belgium
	Discussion
1045	SESSION NINE | Invasive TCC
	Management of Invasive Bladder Cancer in the Elderly: Michael Cookson, USA
	Upper tract TCC: Role of Neoadjuvant Therapy: Surena Matin, USA
	Gene Therapy and Bladder Cancer: TBA
	Neoadjuvant/Adjuvant Chemotherapy in the Elderly: Friedemann Honecker, Germany
	Debate: Adjuvant Is Preferable to Neo-Adjuvant: Friedemann Honecker vs Peter Albers, Germany
	Discussion
1215	ADJOURN